Prescription medication · Estrogen Hormone
estradiol
Also sold as Estrace, Vivelle-Dot. Iclevia is used by women who can get pregnant to prevent pregnancy.
Data updated 2026-05-15
- 83,781
- FDA reportsOften reported
- 54
- InteractionsMany interactions
- 58% less
- Generic vs brandBig savings
- 17
- Recall records
What the data shows
estradiol (Estrace) is a prescription Estrogen Hormone, more reported than most tracked drugs (83,781 FDA reports), whose generic runs roughly half the brand price or less (58% less).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
estradiol (Estrace) is a prescription Estrogen Hormone. Iclevia is used by women who can get pregnant to prevent pregnancy.
Iclevia is a birth control pill. It contains two hormones, a progestin and an estrogen, that work together to prevent pregnancy.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$18.44/unit
Generic Price
$7.76/unit
Generic Savings
58%
Generic Available
Yes (37 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Iclevia is used by women who can get pregnant to prevent pregnancy.
Common side effects
Headache, Heavy menstrual bleeding, Nausea
Key warnings
Cigarette smoking increases your risk of serious heart problems from birth control pills.
The sections below are summarized in plain English from estradiol's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Iclevia contains two hormones: levonorgestrel (a progestin) and ethinyl estradiol (an estrogen). These hormones prevent pregnancy by stopping ovulation (the release of an egg from the ovary). They also change the lining of the uterus to prevent a fertilized egg from implanting.
How to Take It
Take one Iclevia tablet every day, at the same time each day. Take the tablets in the order shown on the package. You will take white pills for 84 days, then green pills for 7 days. Start your next pack immediately after finishing the previous one.
This is a plain-language summary of estradiol's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.
Pregnancy & Breastfeeding
Do not use Iclevia if you are pregnant. If you become pregnant while taking Iclevia, stop taking it right away. Iclevia can reduce milk production, so you may want to use a different birth control method while breastfeeding.
This is a plain-language summary of estradiol's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.
Missed Dose
If you miss a white (active) pill, take it as soon as you remember. Then, take your next pill at your regular time. If you miss more than one pill, follow the instructions in the package insert. Use a backup method of birth control (like condoms) for 7 days if you miss pills.
This is a plain-language summary of estradiol's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.
Storage
Store Iclevia at room temperature (68° to 77°F) and protect it from light.
Side Effects (from patient reports)
Based on 83,781 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for estradiol, by number of reports
- The product did not stick properly
The product did not stick properly
5,172 reports
- Headache
Headache
5,035 reports
- Nausea
Nausea
4,752 reports
- Tiredness
Tiredness
4,511 reports
- Pain
Pain
3,478 reports
- Hot flash
Hot flash
3,279 reports
- Diarrhea
Diarrhea
3,057 reports
- Dizziness
Dizziness
2,921 reports
- Joint pain
Joint pain
2,816 reports
- Rash
Rash
2,502 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for estradiol each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where estradiol sits
estradiol has more FDA adverse-event reports than 83% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is estradiol; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 83,781 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2000–2025.
Total Reports
83,781
Reports Mentioning Death
1,484
1.8% of reports — not proof of cause
Hospitalization Reports
11,279
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 3 | PRODUCT ADHESION ISSUE | 5,172 |
| 4 | HEADACHE | 5,036 |
| 5 | NAUSEA | 4,754 |
| 6 | FATIGUE | 4,511 |
| 7 | PAIN | 3,480 |
| 8 | HOT FLUSH | 3,279 |
| 9 | DIARRHOEA | 3,056 |
| 10 | DIZZINESS | 2,921 |
| 11 | ARTHRALGIA | 2,816 |
| 12 | RASH | 2,502 |
| 13 | DYSPNOEA | 2,440 |
| 14 | BREAST CANCER FEMALE | 2,439 |
| 15 | PRURITUS | 2,433 |
| 16 | PRODUCT QUALITY ISSUE | 2,425 |
| 17 | INSOMNIA | 2,415 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Cigarette smoking increases your risk of serious heart problems from birth control pills. This risk is higher if you are over 35 and smoke more cigarettes. You should not take Iclevia if you are over 35 and smoke.
Known Drug Interactions
Potential to Increase Serum Potassium Concentration There is a potential for an increase in serum potassium concentration in women taking drospirenone, ethinyl estradiol and levomefolate calcium tablets and levomefolate calcium tablets with other drugs that may increase serum potassium concentration [see Warnings And Precautions ( 5.2 ) and And Clinical Pharmacology ( 12.3 )]. 7.3 Concomitant Use with HCV Combination Therapy – Liver Enzyme Elevation Do not co-administer drospirenone, ethinyl estradiol and levomefolate calcium tablets and levomefolate calcium tablets with HCV drug...
Mechanism: Drospirenone can cause your body to keep too much potassium, and taking it with other similar drugs can make this effect stronger.
What to do: Your doctor should check your blood potassium levels regularly while you are on these medications.
Co-administration of Iclevia and glecaprevir/pibrentasvir is not recommended due to potential for ALT elevations.
Mechanism: Taking these two drugs at the same time can cause a rise in liver enzymes. This is a sign that the combination might be harmful to your liver.
What to do: This combination is not recommended. Talk to your doctor about using a different treatment to protect your liver health.
Counsel women to use an alternative non-hormonal method of contraception or a back-up method when enzyme inducers are used with Etonogestrel and ethinyl estradiol vaginal ring, and to continue back-up non-hormonal contraception for 28 days after discontinuing the enzyme inducer to ensure contraceptive reliability. Note: Etonogestrel and ethinyl estradiol vaginal ring may interfere with the correct placement and position of certain female barrier methods such as a diaphragm or female condom. These methods are not recommended as back-up methods with Etonogestrel and ethinyl estradiol vaginal...
Mechanism: Certain medications can speed up how the body breaks down birth control hormones. This makes the birth control less effective and increases the risk of pregnancy.
What to do: Use a backup birth control method, like condoms, while taking these drugs. Keep using backup for 28 days after you stop the interacting medication.
Mild or Moderate CYP3A Inhibitors: Clotrimazole, antibiotics (e.g., verapamil, diltiazem, nifedipine, nicardipine), amiodarone, danazol, ethinyl estradiol, cimetidine, lansoprazole and omeprazole May increase tacrolimus whole blood trough concentrations and increase the risk of serious adverse reactions (e.g., neurotoxicity, QT prolongation) [see Warnings and Precautions ( 5.7 , 5.10 , 5.11 )] .
Mechanism: Estradiol can slow down how your body breaks down tacrolimus, which may increase the amount of medicine in your blood to unsafe levels.
What to do: Your healthcare provider should check your blood levels and watch for any signs of toxicity while you are using both medications.
Substances increasing the systemic exposure of COCs: Co-administration of atorvastatin or rosuvastatin and certain COCs containing ethinyl estradiol (EE) increase AUC values for EE by approximately 20 to 25%.
Mechanism: Rosuvastatin can increase the amount of estrogen that stays in your body.
What to do: Talk to your doctor about this combination, as higher hormone levels may increase your risk of side effects.
This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.
Common Questions
What should I do if I experience breakthrough bleeding?
Can I take Iclevia if I have high blood pressure?
Does Iclevia protect against STIs?
Can I take Iclevia if I have a history of blood clots?
What if I have surgery?
Can I take Iclevia if I am breastfeeding?
What if I have liver problems?
Can other medicines affect Iclevia?
What if I have diabetes?
What are the ingredients in Iclevia?
What are the common side effects of estradiol?
Does estradiol interact with other medications?
What drug class is estradiol?
Is there a generic version of estradiol?
Is estradiol safe during pregnancy?
Has estradiol been recalled?
Active Recalls
Defective Container; packets were found to be either empty or partially full.
ANI Pharmaceuticals, Inc.
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Presence of Foreign substance - potential presence of metal particulate matter
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Failed Content Uniformity Specifications
AvKARE
Failed Impurities/Degradation Specifications.
Zydus Pharmaceuticals (USA) Inc
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Teva Pharmaceuticals USA, Inc
Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.
Padagis US LLC
Lack of Assurance of Sterility
TMC Acquisition LLC dba Tailor Made Compounding
Failed Stability Specifications; out of specification for shear.
Noven Pharmaceuticals Inc
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Related Medications in Estrogen Hormone
Other drugs grouped near estradiol - same-class peers and common alternatives.
abiraterone
Zytiga
Abiraterone (Zytiga) is a medicine used with prednisone to treat prostate cancer that has spread.
Compare with estradiol →
anastrozole
Arimidex
Anastrozole is a medicine used to treat breast cancer in women after menopause.
Compare with estradiol →
bazedoxifene/conjugated estrogens
Duavee
Duavee is a combination medicine containing estrogen and a drug that blocks estrogen in some parts of the body.
Compare with estradiol →
cabergoline
Dostinex
Cabergoline is a medicine that helps lower the amount of prolactin in your body.
Compare with estradiol →
clomiphene
Clomid, Serophene
Clomiphene citrate is a medicine that helps women ovulate.
Compare with estradiol →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on estradiol
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for estradiol
The FDA label for estradiol (sold under brand names such as Estrace, Vivelle-Dot) classifies it as a prescription-only medication in the Estrogen Hormone class. Iclevia is used by women who can get pregnant to prevent pregnancy. Official labeling lists 9 commonly reported side effects, including Headache, Heavy menstrual bleeding, Nausea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 83,781 voluntary reports. The database also lists 54 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $7.76 versus $18.44 for the brand - a 58% generic savings.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 17 recall records on file), and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: July 2, 2024
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages